Jae-hyeok Kang

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Colony-stimulating factor 3 as a key mediator in the progression of idiopathic pulmonary fibrosis: a novel therapeutic target.

Colony-stimulating factor 3 as a key mediator in the progression of idiopathic pulmonary fibrosis: a novel therapeutic target.

Journal: Signal transduction and targeted therapy

Published: January 13, 2025

Tumor-intrinsic role of ICAM-1 in driving metastatic progression of triple-negative breast cancer through direct interaction with EGFR.

Tumor-intrinsic role of ICAM-1 in driving metastatic progression of triple-negative breast cancer through direct interaction with EGFR.

Journal: Molecular cancer

Published: May 14, 2024

Correction: GPR110 promotes progression and metastasis of triple-negative breast cancer.

Correction: GPR110 promotes progression and metastasis of triple-negative breast cancer.

Journal: Cell death discovery

Published: December 08, 2022

Correction: ICAM-1 promotes cancer progression by regulating SRC activity as an adapter protein in colorectal cancer.

Correction: ICAM-1 promotes cancer progression by regulating SRC activity as an adapter protein in colorectal cancer.

Journal: Cell death & disease

Published: November 18, 2022

Glioblastoma-educated mesenchymal stem-like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment.

Glioblastoma-educated mesenchymal stem-like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment.

Journal: Clinical and translational medicine

Published: March 02, 2022

GPR110 promotes progression and metastasis of triple-negative breast cancer.

GPR110 promotes progression and metastasis of triple-negative breast cancer.

Journal: Cell death discovery

Published: November 12, 2021

ICAM-1 promotes cancer progression by regulating SRC activity as an adapter protein in colorectal cancer.

ICAM-1 promotes cancer progression by regulating SRC activity as an adapter protein in colorectal cancer.

Journal: Cell death & disease

Published: October 28, 2021

K-RAS Acts as a Critical Regulator of CD44 to Promote the Invasiveness and Stemness of GBM in Response to Ionizing Radiation.

K-RAS Acts as a Critical Regulator of CD44 to Promote the Invasiveness and Stemness of GBM in Response to Ionizing Radiation.

Journal: International journal of molecular sciences

Published: July 15, 2021

Soluble ICAM-1 a Pivotal Communicator between Tumors and Macrophages, Promotes Mesenchymal Shift of Glioblastoma.

Soluble ICAM-1 a Pivotal Communicator between Tumors and Macrophages, Promotes Mesenchymal Shift of Glioblastoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 29, 2021

Loss of FBXL14 promotes mesenchymal shift and radioresistance of non-small cell lung cancer by TWIST1 stabilization.

Loss of FBXL14 promotes mesenchymal shift and radioresistance of non-small cell lung cancer by TWIST1 stabilization.

Journal: Signal transduction and targeted therapy

Published: November 17, 2020

FBXO15 plays a critical suppressive functional role in regulation of breast cancer progression.

FBXO15 plays a critical suppressive functional role in regulation of breast cancer progression.

Journal: Signal transduction and targeted therapy

Published: September 18, 2020

Genome-scale screening of deubiquitinase subfamily identifies USP3 as a stabilizer of Cdc25A regulating cell cycle in cancer.

Genome-scale screening of deubiquitinase subfamily identifies USP3 as a stabilizer of Cdc25A regulating cell cycle in cancer.

Journal: Cell death and differentiation

Published: November 05, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026